147 related articles for article (PubMed ID: 17907264)
1. Reduced brain glutamate in patients with Parkinson's disease.
Griffith HR; Okonkwo OC; O'Brien T; Hollander JA
NMR Biomed; 2008 May; 21(4):381-7. PubMed ID: 17907264
[TBL] [Abstract][Full Text] [Related]
2. Influences of dopaminergic treatment on motor cortex in Parkinson disease: a MRI/MRS study.
Lucetti C; Del Dotto P; Gambaccini G; Ceravolo R; Logi C; Berti C; Rossi G; Bianchi MC; Tosetti M; Murri L; Bonuccelli U
Mov Disord; 2007 Nov; 22(15):2170-5. PubMed ID: 17722082
[TBL] [Abstract][Full Text] [Related]
3. Brain N-acetylaspartate is reduced in Parkinson disease with dementia.
Griffith HR; den Hollander JA; Okonkwo OC; O'Brien T; Watts RL; Marson DC
Alzheimer Dis Assoc Disord; 2008; 22(1):54-60. PubMed ID: 18317247
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance spectroscopic evidence for presupplementary motor area neuronal dysfunction in Parkinson's disease.
Camicioli RM; Hanstock CC; Bouchard TP; Gee M; Fisher NJ; Martin WR
Mov Disord; 2007 Feb; 22(3):382-6. PubMed ID: 17216652
[TBL] [Abstract][Full Text] [Related]
5. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
Wang Z; Zhao C; Yu L; Zhou W; Li K
Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
[TBL] [Abstract][Full Text] [Related]
6. Temporal window of metabolic brain vulnerability to concussion: a pilot 1H-magnetic resonance spectroscopic study in concussed athletes--part III.
Vagnozzi R; Signoretti S; Tavazzi B; Floris R; Ludovici A; Marziali S; Tarascio G; Amorini AM; Di Pietro V; Delfini R; Lazzarino G
Neurosurgery; 2008 Jun; 62(6):1286-95; discussion 1295-6. PubMed ID: 18824995
[TBL] [Abstract][Full Text] [Related]
7. Unchanged basal ganglia N-acetylaspartate and glutamate in idiopathic Parkinson's disease measured by proton magnetic resonance spectroscopy.
Clarke CE; Lowry M; Horsman A
Mov Disord; 1997 May; 12(3):297-301. PubMed ID: 9159722
[TBL] [Abstract][Full Text] [Related]
8. Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting.
Almuqbel M; Melzer TR; Myall DJ; MacAskill MR; Pitcher TL; Livingston L; Wood KL; Keenan RJ; Dalrymple-Alford JC; Anderson TJ
Parkinsonism Relat Disord; 2016 Jan; 22():54-61. PubMed ID: 26627939
[TBL] [Abstract][Full Text] [Related]
9. Brainstem 1H-MR spectroscopy in patients with Parkinson's disease with REM sleep behavior disorder and IPD patients without dream enactment behavior.
Hanoglu L; Ozer F; Meral H; Dincer A
Clin Neurol Neurosurg; 2006 Feb; 108(2):129-34. PubMed ID: 15936138
[TBL] [Abstract][Full Text] [Related]
10. Glutamate concentrations in human brain using single voxel proton magnetic resonance spectroscopy at 3 Tesla.
Schubert F; Gallinat J; Seifert F; Rinneberg H
Neuroimage; 2004 Apr; 21(4):1762-71. PubMed ID: 15050596
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance spectroscopy reveals an epileptic network in juvenile myoclonic epilepsy.
Lin K; Carrete H; Lin J; Peruchi MM; de Araújo Filho GM; Guaranha MS; Guilhoto LM; Sakamoto AC; Yacubian EM
Epilepsia; 2009 May; 50(5):1191-200. PubMed ID: 19220412
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
[TBL] [Abstract][Full Text] [Related]
13. Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder.
Yücel M; Wood SJ; Wellard RM; Harrison BJ; Fornito A; Pujol J; Velakoulis D; Pantelis C
Aust N Z J Psychiatry; 2008 Jun; 42(6):467-77. PubMed ID: 18465373
[TBL] [Abstract][Full Text] [Related]
14. [Hydrogen proton MR spectroscopy of posterior portion cingulate gyrus of patients with Alzheimer's disease: a case control study].
Wang T; Xiao SF; Li X; Wang Y; Ding B; Ling HW; Chen KM
Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(1):37-40. PubMed ID: 19489242
[TBL] [Abstract][Full Text] [Related]
15. [Quantitation of glutamate in the brain by using MR proton spectroscopy at 1.5 T and 3 T].
Gussew A; Rzanny R; Scholle HC; Kaiser WA; Reichenbach JR
Rofo; 2008 Aug; 180(8):722-32. PubMed ID: 18512190
[TBL] [Abstract][Full Text] [Related]
16. [Magnetic resonance spectroscopy in Parkinson's disease and multiple system atrophy].
Aotsuka A; Shinotoh H; Hattori T
Nihon Rinsho; 1997 Jan; 55(1):249-54. PubMed ID: 9014459
[TBL] [Abstract][Full Text] [Related]
17. In vivo 1H magnetic resonance spectroscopy-derived metabolite variations between acute-on-chronic liver failure and acute liver failure.
Verma A; Saraswat VA; Radha Krishna Y; Nath K; Thomas MA; Gupta RK
Liver Int; 2008 Sep; 28(8):1095-103. PubMed ID: 18266634
[TBL] [Abstract][Full Text] [Related]
18. Metabolic changes in the normal ageing brain: consistent findings from short and long echo time proton spectroscopy.
Gruber S; Pinker K; Riederer F; Chmelík M; Stadlbauer A; Bittsanský M; Mlynárik V; Frey R; Serles W; Bodamer O; Moser E
Eur J Radiol; 2008 Nov; 68(2):320-7. PubMed ID: 17964104
[TBL] [Abstract][Full Text] [Related]
19. Intact presupplementary motor area function in early, untreated Parkinson's disease.
Martin WR; Wieler M; Gee M; Hanstock CC; Camicioli RM
Mov Disord; 2008 Sep; 23(12):1756-9. PubMed ID: 18709678
[TBL] [Abstract][Full Text] [Related]
20. Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson's disease, the MPTP-intoxicated mouse.
Chassain C; Bielicki G; Durand E; Lolignier S; Essafi F; Traoré A; Durif F
J Neurochem; 2008 May; 105(3):874-82. PubMed ID: 18088356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
